NCT00379483View on ClinicalTrials.gov

Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Transfusional Iron Overload
Interventions
DRUG

Deferasirox

Trial Locations (4)

Unknown

Novartis Investigative Site, Cagliari

Novartis Investigative Site, Genova

Novartis Investigative Site, Milan

Novartis Investigative Site, Torino

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY